{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:08:58Z","timestamp":1791648538219,"version":"4.3.4"},"reference-count":82,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,1,1]]},"DOI":"10.2169\/internalmedicine.2867-23","type":"journal-article","created":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T22:16:02Z","timestamp":1699827362000},"page":"7-15","source":"Crossref","is-referenced-by-count":23,"title":["Management of Chronic Constipation: A Comprehensive Review"],"prefix":"10.2169","volume":"64","author":[{"given":"Mariko","family":"Hojo","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Juntendo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyoshi","family":"Shibuya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Juntendo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Nagahara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Juntendo University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. The Japanese Gastroenterological Association. Evidence-Based Clinical Practice Guidelines for Chronic Constipation. Nankodo, Tokyo, 2023 (in Japanese)."},{"key":"2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","volume":"150","author":"F Mearin","year":"2016","unstructured":"2. Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology 150: 1393-1407, 2016.","journal-title":"Gastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Palsson OS, Whitehead W, T\u00f6rnblom H, Sperber AD, Simren M. Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom. Gastroenterology 158: 1262-1273.e3, 2020.","DOI":"10.1053\/j.gastro.2019.12.021"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Schmidt FMQ, de Gouveia Santos VLC. Prevalence of constipation in the general adult population: an integrative review. J Wound Ostomy Continence Nurs 41: 70-76; quiz E1-E2, 2014.","DOI":"10.1097\/01.WON.0000438019.21229.b7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ruszkowski J, Heleniak Z, Kr\u00f3l E, et al. Constipation and the quality of life in conservatively treated chronic kidney disease patients: a cross-sectional study. Int J Med Sci 17: 2954-2963, 2020.","DOI":"10.7150\/ijms.49648"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chang JY, Locke GR 3rd, McNally MA, et al. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol 105: 822-832, 2010.","DOI":"10.1038\/ajg.2010.40"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Choung RS, Rey E, Richard Locke G 3rd, et al. Chronic constipation and co-morbidities: a prospective population-based nested case-control study. United European Gastroenterol J 4: 142-151, 2016.","DOI":"10.1177\/2050640614558476"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Brandt LJ, Prather CM, Quigley EM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 100: S5-S21, 2005.","DOI":"10.1111\/j.1572-0241.2005.50613_2.x"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Wald A. Constipation: advances in diagnosis and treatment. JAMA 315: 185-191, 2016.","DOI":"10.1001\/jama.2015.16994"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Chang L, Chey WD, Imdad A, et al. American Gastroenterological Association-American College of Gastroenterology clinical practice guideline: pharmacological management of chronic idiopathic constipation. Gastroenterology 164: 1086-1106, 2023.","DOI":"10.1053\/j.gastro.2023.03.214"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lindberg G, Hamid SS, Malfertheiner P, et al. World Gastroenterology Organisation global guideline: constipation - a global perspective. J Clin Gastroenterol 45: 483-487, 2011.","DOI":"10.1097\/MCG.0b013e31820fb914"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Bharucha AE, Dorn SD, Lembo A, Pressman A. American Gastroenterological Association medical position statement on constipation. Gastroenterology 144: 211-217, 2013.","DOI":"10.1053\/j.gastro.2012.10.029"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Belsey J, Greenfield S, Candy D, Geraint M. Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther 31: 938-949, 2010.","DOI":"10.1111\/j.1365-2036.2010.04273.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 25: 599-608, 2007.","DOI":"10.1111\/j.1365-2036.2006.03238.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Campbell AJ, Busby WJ, Horwath CC. Factors associated with constipation in a community based sample of people aged 70 years and over. J Epidemiol Community Health 47: 23-26, 1993.","DOI":"10.1136\/jech.47.1.23"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Dukas L, Willett WC, Giovannucci EL. Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women. Am J Gastroenterol 98: 1790-1796, 2003.","DOI":"10.1111\/j.1572-0241.2003.07591.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Alessi CA, Henderson CT. Constipation and fecal impaction in the long-term care patient. Clin Geriatr Med 4: 571-588, 1988.","DOI":"10.1016\/S0749-0690(18)30735-3"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gao R, Tao Y, Zhou C, et al. Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials. Scand J Gastroenterol 54: 169-177, 2019.","DOI":"10.1080\/00365521.2019.1568544"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet 393: 434-445, 2019.","DOI":"10.1016\/S0140-6736(18)31809-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Murakami K, Sasaki S, Okubo H, et al. Association between dietary fiber, water and magnesium intake and functional constipation among young Japanese women. Eur J Clin Nutr 61: 616-622, 2007.","DOI":"10.1038\/sj.ejcn.1602573"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Towers AL, Burgio KL, Locher JL, Merkel IS, Safaeian M, Wald A. Constipation in the elderly: influence of dietary, psychological, and physiological factors. J Am Geriatr Soc 42: 701-706, 1994.","DOI":"10.1111\/j.1532-5415.1994.tb06527.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Christodoulides S, Dimidi E, Fragkos KC, Farmer AD, Whelan K, Scott SM. Systematic review with meta-analysis: effect of fibre supplementation on chronic idiopathic constipation in adults. Aliment Pharmacol Ther 44: 103-116, 2016.","DOI":"10.1111\/apt.13662"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Higgins JP, Altman DG, G\u00f8tzsche PC, et al.; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343: d5928, 2011.","DOI":"10.1136\/bmj.d5928"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Leung L, Riutta T, Kotecha J, Rosser W. Chronic constipation: an evidence-based review. J Am Board Fam Med 24: 436-451, 2011.","DOI":"10.3122\/jabfm.2011.04.100272"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Li Y, Tong WD, Qian Y. Effect of physical activity on the association between dietary fiber and constipation: evidence from the National Health and Nutrition Examination Survey 2005-2010. J Neurogastroenterol Motil 27: 97-107, 2021.","DOI":"10.5056\/jnm20051"},{"key":"26","unstructured":"26. Klauser AG, Beck A, Schindlbeck NE, M\u00fcller-Lissner SA. Low fluid intake lowers stool output in healthy male volunteers. Z Gastroenterol 28: 606-609, 1990."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Park M, Bang YG, Cho KY. Risk factors for functional constipation in young children attending daycare centers. J Korean Med Sci 31: 1262-1265, 2016.","DOI":"10.3346\/jkms.2016.31.8.1262"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Chung BD, Parekh U, Sellin JH. Effect of increased fluid intake on stool output in normal healthy volunteers. J Clin Gastroenterol 28: 29-32, 1999.","DOI":"10.1097\/00004836-199901000-00006"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Boilesen SN, Tahan S, Dias FC, Melli L, de Morais MB. Water and fluid intake in the prevention and treatment of functional constipation in children and adolescents: is there evidence? J Pediatr (Rio J) 93: 320-327, 2017.","DOI":"10.1016\/j.jped.2017.01.005"},{"key":"30","first-page":"727","volume":"45","author":"M Anti","year":"1998","unstructured":"30. Anti M, Pignataro G, Armuzzi A, et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 45: 727-732, 1998.","journal-title":"Hepatogastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0172-6390","issn-type":"print"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Marteau P, Flouri\u00e9 B, Cherbut C, et al. Digestibility and bulking effect of ispaghula husks in healthy humans. Gut 35: 1747-1752, 1994.","DOI":"10.1136\/gut.35.12.1747"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Suares NC, Ford AC. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther 33: 895-901, 2011.","DOI":"10.1111\/j.1365-2036.2011.04602.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Takahashi H, Wako N, Okubo T, Ishihara N, Yamanaka J, Yamamoto T. Influence of partially hydrolyzed guar gum on constipation in women. J Nutr Sci Vitaminol 40: 251-259, 1994.","DOI":"10.3177\/jnsv.40.251"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Polymeros D, Beintaris I, Gaglia A, et al. Partially hydrolyzed guar gum accelerates colonic transit time and improves symptoms in adults with chronic constipation. Dig Dis Sci 59: 2207-2214, 2014.","DOI":"10.1007\/s10620-014-3135-1"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Chan TC, Yu VMW, Luk JKH, Chu LW, Yuen JKY, Chan FHW. Effectiveness of partially hydrolyzed guar gum in reducing constipation in long term care facility residents: a randomized single-blinded placebo-controlled trial. J Nutr Health Aging 26: 247-251, 2022.","DOI":"10.1007\/s12603-022-1747-2"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Badiali D, Corazziari E, Habib FI, et al. Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial. Dig Dis Sci 40: 349-356, 1995.","DOI":"10.1007\/BF02065421"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Mori S, Tomita T, Fujimura K, et al. A randomized double-blind placebo-controlled trial on the effect of magnesium oxide in patients with chronic constipation. J Neurogastroenterol Motil 25: 563-575, 2019.","DOI":"10.5056\/jnm18194"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Morishita D, Tomita T, Mori S, et al. Senna versus magnesium oxide for the treatment of chronic constipation: a randomized, placebo-controlled trial. Am J Gastroenterol 116: 152-161, 2021.","DOI":"10.14309\/ajg.0000000000000942"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Horibata K, Tanoue A, Ito M, Takemura Y. Relationship between renal function and serum magnesium concentration in elderly outpatients treated with magnesium oxide. Geriatr Gerontol Int 16: 600-605, 2016.","DOI":"10.1111\/ggi.12530"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Yoshimura Y, Fujisaki K, Yamamoto T, Shinohara Y. Pharmacokinetic studies of orally administered magnesium oxide in rats. Yakugaku Zasshi (J Pham Soc Jpn) 137: 581-587, 2017 (in Japanese).","DOI":"10.1248\/yakushi.16-00020"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Yamasaki M, Funakoshi S, Matsuda S, et al. Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy. Eur J Clin Pharmacol 70: 921-924, 2014.","DOI":"10.1007\/s00228-014-1694-x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Nakajima A, Shinbo K, Oota A, Kinoshita Y. Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension. J Gastroenterol 54: 792-803, 2019.","DOI":"10.1007\/s00535-019-01581-x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. DiPalma JA, Cleveland MV, McGowan J, Herrera JL. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol 102: 1436-1441, 2007.","DOI":"10.1111\/j.1572-0241.2007.01199.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Corazziari E, Badiali D, Bazzocchi G, et al. Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut 46: 522-526, 2000.","DOI":"10.1136\/gut.46.4.522"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Corazziari E, Badiali D, Habib FI, et al. Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation. Dig Dis Sci 41: 1636-1642, 1996.","DOI":"10.1007\/BF02087913"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MB. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 95: 446-450, 2000.","DOI":"10.1111\/j.1572-0241.2000.01765.x"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Kasugai K, Iwai H, Kuboyama N, Yoshikawa A, Fukudo S. Efficacy and safety of a crystalline lactulose preparation (SK-1202) in Japanese patients with chronic constipation: a randomized, double-blind, placebo-controlled, dose-finding study. J Gastroenterol 54: 530-540, 2019.","DOI":"10.1007\/s00535-018-01545-7"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Camilleri M, Bharucha AE, Ueno R, et al. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol 290: G942-G947, 2006.","DOI":"10.1152\/ajpgi.00264.2005"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Moeser AJ, Nighot PK, Engelke KJ, Ueno R, Blikslager AT. Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone. Am J Physiol Gastrointest Liver Physiol 292: G647-G656, 2007.","DOI":"10.1152\/ajpgi.00183.2006"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Cryer B, Drossman DA, Chey WD, Webster L, Habibi S, Wang M. Analysis of nausea in clinical studies of lubiprostone for the treatment of constipation disorders. Dig Dis Sci 62: 3568-3578, 2017.","DOI":"10.1007\/s10620-017-4680-1"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Fukudo S, Hongo M, Kaneko H, Ueno R. Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study. Neurogastroenterol Motil 23: 544-e205, 2011.","DOI":"10.1111\/j.1365-2982.2011.01668.x"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Johanson JF, Ueno R. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety. Aliment Pharmacol Ther 25: 1351-1361, 2007.","DOI":"10.1111\/j.1365-2036.2007.03320.x"},{"key":"53","doi-asserted-by":"publisher","unstructured":"53. Castro J, Harrington AM, Hughes PA, et al. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate. Gastroenterology 145: 1334-1346.e1-11, 2013.","DOI":"10.1053\/j.gastro.2013.08.017"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Yang J, Lei Y. Comparison of the efficacy and safety of different doses of linaclotide for patients with chronic constipation: a meta-analysis and Bayesian analysis. Evid Based Complement Alternat Med 2021: 9923879, 2021.","DOI":"10.1155\/2021\/9923879"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Bunnett NW. Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract. J Physiol 592: 2943-2950, 2014.","DOI":"10.1113\/jphysiol.2014.271155"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Vollebregt PF, Burgell RE, Hooper RL, Knowles CH, Scott SM. Clinical impact of rectal hyposensitivity: a cross-sectional study of 2,876 patients with refractory functional constipation. Am J Gastroenterol 116: 758-768, 2021.","DOI":"10.14309\/ajg.0000000000001039"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Bampton PA, Dinning PG, Kennedy ML, Lubowski DZ, Cook IJ. The proximal colonic motor response to rectal mechanical and chemical stimulation. Am J Physiol Gastrointest Liver Physiol 282: G443-G449, 2002.","DOI":"10.1152\/ajpgi.00194.2001"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Nakajima A, Seki M, Taniguchi S, et al. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Lancet Gastroenterol Hepatol 3: 537-547, 2018.","DOI":"10.1016\/S2468-1253(18)30123-7"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Nakajima A, Shoji A, Kokubo K, Igarashi A. A systematic review and network meta-analysis on the efficacy of medications in the treatment of chronic idiopathic constipation in Japan. Gastroenterol Res Pract 2021: 5534687, 2021.","DOI":"10.1155\/2021\/5534687"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Corsetti M, Landes S, Lange R. Bisacodyl: a review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation. Neurogastroenterol Motil 33: e14123, 2021.","DOI":"10.1111\/nmo.14123"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Portalatin M, Winstead N. Medical management of constipation. Clin Colon Rectal Surg 25: 12-19, 2012.","DOI":"10.1055\/s-0032-1301754"},{"key":"62","doi-asserted-by":"publisher","unstructured":"62. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 60: 209-218, 2011.","DOI":"10.1136\/gut.2010.227132"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Ghadially FN, Walley VM. Melanoses of the gastrointestinal tract. Histopathology 25: 197-207, 1994.","DOI":"10.1111\/j.1365-2559.1994.tb01319.x"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Riemann JF, Schmidt H, Zimmermann W. The fine structure of colonic submucosal nerves in patients with chronic laxative abuse. Scand J Gastroenterol 15: 761-768, 1980.","DOI":"10.3109\/00365528009181527"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Preston DM, Lennard-Jones JE. Severe chronic constipation of young women: 'idiopathic slow transit constipation'. Gut 27: 41-48, 1986.","DOI":"10.1136\/gut.27.1.41"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Leng-Peschlow E, Odenthal KP, Voderholzer W, M\u00fcller-Lissner S. Chronic sennoside treatment does not cause habituation and secondary hyperaldosteronism in rats. Pharmacology 47: 162-171, 1993.","DOI":"10.1159\/000139856"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. M\u00fcller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am J Gastroenterol 100: 232-242, 2005.","DOI":"10.1111\/j.1572-0241.2005.40885.x"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 100: 1075-1084, 2014.","DOI":"10.3945\/ajcn.114.089151"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Sajid MS, Hebbar M, Baig MK, Li A, Philipose Z. Use of prucalopride for chronic constipation: a systematic review and meta-analysis of published randomized, controlled trials. J Neurogastroenterol Motil 22: 412-422, 2016.","DOI":"10.5056\/jnm16004"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Ueno N, Inui A, Satoh Y. The effect of mosapride citrate on constipation in patients with diabetes. Diabetes Res Clin Pract 87: 27-32, 2010.","DOI":"10.1016\/j.diabres.2009.09.024"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Sasaki K, Yamauchi K, Kuwano S. Metabolic activation of sennoside A in mice. Planta Med 37: 370-378, 1979.","DOI":"10.1055\/s-0028-1097352"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Iizuka N, Hamamoto Y. Constipation and herbal medicine. Front Pharmacol 6: 73, 2015.","DOI":"10.3389\/fphar.2015.00073"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Shimada Y. Adverse effects of Kampo medicines. Intern Med 61: 29-35, 2022.","DOI":"10.2169\/internalmedicine.6292-20"},{"key":"74","doi-asserted-by":"publisher","unstructured":"74. Manabe N, Nakajima A, Odaka T, Haruma K. Daikenchuto significantly improves stool consistency and lower gastrointestinal symptoms in patients with chronic constipation. JGH Open 7: 182-189, 2023.","DOI":"10.1002\/jgh3.12870"},{"key":"75","unstructured":"75. Mueller-Lissner SA, Wald A. Constipation in adults. BMJ Clin Evid 2010: 0413, 2010."},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Hayashida R, Tsuchiya K, Nakamura S, et al. Acute kidney injury with hemolysis after glycerin enema-induced rectal injury in a patient with type 2 diabetes. Intern Med 59: 1659-1663, 2020.","DOI":"10.2169\/internalmedicine.4217-19"},{"key":"77","doi-asserted-by":"publisher","unstructured":"77. H\u00e4gnevik K, Gordon E, Lins LE, Wilhelmsson S, Forster D. Glycerol-induced haemolysis with haemoglobinuria and acute renal failure. Report of three cases. Lancet 1: 75-77, 1974.","DOI":"10.1016\/S0140-6736(02)95560-1"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Gl\u00e4ssner K. Therapeutische Versuche bei habitueller Obstipation. Archiv f\u00fcr verdauungskrankheiten 52: 43-49, 1932.","DOI":"10.1159\/000196594"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Schang JC, H\u00e9mond M, H\u00e9bert M, Pilote M. Changes in colonic myoelectric spiking activity during stimulation by bisacodyl. Can J Physiol Pharmacol 64: 39-43, 1986.","DOI":"10.1139\/y86-005"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Serra J, Pohl D, Azpiroz F, et al. European society of neurogastroenterology and motility guidelines on functional constipation in adults. Neurogastroenterol Motil 32: e13762, 2020.","DOI":"10.1111\/nmo.13762"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Rao SS, Benninga MA, Bharucha AE, Chiarioni G, Di Lorenzo C, Whitehead WE. ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders. Neurogastroenterol Motil 27: 594-609, 2015.","DOI":"10.1111\/nmo.12520"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Moore D, Young CJ. A systematic review and meta-analysis of biofeedback therapy for dyssynergic defaecation in adults. Tech Coloproctol 24: 909-918, 2020.","DOI":"10.1007\/s10151-020-02230-9"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/1\/64_2867-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T03:24:00Z","timestamp":1735961040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/1\/64_2867-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2867-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"2867-23"}}